NanoViricides Stock Forecast, Price & News

NanoViricides (NYSEAMERICAN:NNVC) Frequently Asked Questions

How were NanoViricides' earnings last quarter?

NanoViricides, Inc. (NYSEAMERICAN:NNVC) released its earnings results on Monday, November, 15th. The company reported ($0.23) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.20) by $0.03.
View NanoViricides' earnings history.

When did NanoViricides' stock split? How did NanoViricides' stock split work?

NanoViricides's stock reverse split before market open on Tuesday, September 24th 2019. The 1-20 reverse split was announced on Thursday, September 12th 2019. The number of shares owned by shareholders was adjusted after the market closes on Monday, September 23rd 2019. An investor that had 100 shares of NanoViricides stock prior to the reverse split would have 5 shares after the split.

Who are NanoViricides' key executives?

NanoViricides' management team includes the following people:

• Anil R. Diwan, Executive Chairman, President, CEO & Secretary
• Meeta R. Vyas, Chief Financial & Accounting Officer
• Randall W. Barton, Chief Scientific & Regulatory Officer
• Jayant Tatake, Vice President-Research & Development

Who are some of NanoViricides' key competitors?

Some companies that are related to NanoViricides include Opiant Pharmaceuticals (OPNT), Actinium Pharmaceuticals (ATNM), MediciNova (MNOV), Annovis Bio (ANVS), scPharmaceuticals (SCPH), Athenex (ATNX), Immunome (IMNM), Infinity Pharmaceuticals (INFI), Galectin Therapeutics (GALT), BioVie (BIVI), Otonomy (OTIC), Decibel Therapeutics (DBTX), Equillium (EQ), Esperion Therapeutics (ESPR) and Viracta Therapeutics (VIRX).
View all of NNVC's competitors.

What other stocks do shareholders of NanoViricides own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NanoViricides investors own include Cytosorbents (CTSO), Rekor Systems (REKR), Inovio Pharmaceuticals (INO), Micron Technology (MU), Gilead Sciences (GILD), Novavax (NVAX), Sorrento Therapeutics (SRNE), Vaxart (VXRT), iBio (IBIO) and Moderna (MRNA).

What is NanoViricides' stock symbol?

NanoViricides trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "NNVC."

Who are NanoViricides' major shareholders?

NanoViricides' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Cutler Group LP (0.00%).
View institutional ownership trends for NanoViricides.

Which major investors are selling NanoViricides stock?

NNVC stock was sold by a variety of institutional investors in the last quarter, including Cutler Group LP.
View insider buying and selling activity for NanoViricides or view top insider-selling stocks.

How do I buy shares of NanoViricides?

Shares of NNVC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is NanoViricides' stock price today?

One share of NNVC stock can currently be purchased for approximately $2.68.

How much money does NanoViricides make?

NanoViricides has a market capitalization of $30.89 million. The company earns $-8.82 million in net income (profit) each year or ($0.82) on an earnings per share basis.

How many employees does NanoViricides have?

NanoViricides employs 12 workers across the globe.

What is NanoViricides' official website?

The official website for NanoViricides is www.nanoviricides.com.

Where are NanoViricides' headquarters?

NanoViricides is headquartered at 1 Controls Dr, SHELTON, CT 06484-6153, United States.

How can I contact NanoViricides?

NanoViricides' mailing address is 1 Controls Dr, SHELTON, CT 06484-6153, United States. The company can be reached via phone at (203) 937-6137, via email at [email protected], or via fax at 203-859-5095.